UPDATE : Wednesday, September 18, 2019
Celgene’s leukemia drug gets extended insurance coverage by Lee Han-soo 2017-09-04 17:34
Korea UCB gets approval for hemophilia treatment by Marian Chu 2017-09-04 15:32
Bluegreen, Haim Bio sign strategic alliance agreement by Lee Han-soo 2017-09-04 15:11
Roche gets insurance coverage for pregnancy complication detection test by Marian Chu 2017-09-04 11:45
CJ Healthcare submits new drug application for Tegoprazan by Lee Han-soo 2017-09-04 11:32
Eisai gets insurance coverage for thyroid cancer drug by Marian Chu 2017-09-01 13:59
Quratis applies for P2 clinical trial for Korea’s first adult tuberculosis vaccine by Lee Han-soo 2017-09-01 12:04
Gilead, Yuhan to jointly promote hepatitis C drugs by Marian Chu 2017-08-31 17:08
Abbvie gets approval for phase 3 clinical trials to treat Crohn’s disease by Lee Hye-seon 2017-08-31 15:49
Huons to export botulinum toxin worth W100 bil. by Constance Williams 2017-08-31 15:23
Hanmi to manage JVM’s overseas business by Lee Han-soo 2017-08-31 13:51
Opdivo proves competence among local immunotherapies by Marian Chu 2017-08-31 13:47
Novartis gains historic FDA approval for CAR-T leukemia therapy by Marian Chu 2017-08-31 10:52
Gliatamin trademark controversy to head to Supreme Court by Lee Han-soo 2017-08-31 10:00
J&J Innovation opens Seoul competition for medical innovation by Marian Chu 2017-08-31 09:13
Annual output of hypertension, hyperlipidemia drugs surpasses ₩1 tri. respectively by Lee Hye-seon 2017-08-30 16:08
Diabetes, cardiovascular generics actively developed in H1 by Marian Chu 2017-08-30 14:59
CJ Healthcare secures state support for new drug to treat rheumatoid arthritis by Lee Han-soo 2017-08-30 14:20
Terminally-ill patients protest HIRA’s latest ban on off-label prescriptions on immune checkpoint inhibitors by Yang Geum-deok 2017-08-30 14:07
Dong-A ST, Takeda to jointly sell hypertension pill ‘Edarbi’ in Korea by Lee Han-soo 2017-08-30 13:54
Back to Top